Apollomics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oncology therapies designed to harness the immune system and target specific molecular pathways to inhibit cancer. The company's product pipeline includes Vebreltinib (APL-101), an oral selective c-Met inhibitor in Phase 2 trials for non-small cell lung cancer and solid tumors with MET dysregulation; APL-102, a multi-tyrosine kinase inhibitor in Phase 1 development; and APL-122, targeting ErbB signaling pathways for brain cancers in Phase 1 dose escalation trials. Additionally, Apollomics develops immuno-oncology candidates including APL-501, APL-502, and APL-801, as well as uproleselan (APL-106), an E-Selectin antagonist with potential applications in acute myeloid leukemia when used alongside standard chemotherapy. Founded in 2015 and headquartered in Foster City, California, the company addresses unmet medical needs in oncology through its combination approach to cancer treatment.
United States
FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that it has entered into definitive subscription agreements (the “Subscription Agreements”) for a private placement transaction (the “Private Placement”) with certain accredited investors (the “Investors”), fo
Investors talking about APLMW also mention
What share of all stock conversation is about APLMW?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% 0 | 0% +0 | 0% 0 |
Of the messages about APLMW that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 96.62% -0.6 | ||
| Bearish | — | — | — | 3.38% +0.6 |
Of the messages about APLMW that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | 100% | 100% | 100% | 39.84% | ||
| Analysts | 0% | 0% | 0% | 18.72% | ||
| Announcements | 0% | 0% | 0% | 0.53% | ||
| Controversies | 0% | 0% | 0% | 0% | ||
| Earnings | 0% | 0% | 0% | 0% | ||
| Macro | 0% | 0% | 0% | 40.91% |
Of the messages about APLMW, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 75% | 56.76% | 50% | ||
| Newcomers | 0% | 25% | 43.24% | 50% |